REQUEST A DEMO
Total
USD $0.00
Search more companies

Recomedic Damian Macznik sp. k. (Poland)

Main Activities: Pharmacies and Drug Stores
Full name: Recomedic Damian Macznik sp. k. Profile Updated: September 08, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Recomedic Damian Macznik sp. k. is based in Poland. The head office is in Jawor. The company operates in the Pharmacies and Drug Stores sector. It was incorporated on March 02, 2020. The latest financial highlights indicate a net sales revenue increase of 26.91% in 2022. During that time, Recomedic Damian Macznik sp. k.’s total assets grew by 28.93%. The net profit margin of Recomedic Damian Macznik sp. k. decreased by 1.45% in 2022.

Headquarters
Ul. Kuziennicza 10B
Jawor; Dolnoslaskie; Postal Code: 59-400

Contact Details: Purchase the Recomedic Damian Macznik sp. k. report to view the information.

Website: https://recomedic.com

Basic Information
Outstanding Shares:
Purchase the Recomedic Damian Macznik sp. k. report to view the information.
Incorporation Date:
March 02, 2020
Key Executives
Purchase this report to view the information.
Associate Partner
Purchase this report to view the information.
Associate Partner
Purchase this report to view the information.
Limited Partner
Company Performance
Financial values in the chart are available after Recomedic Damian Macznik sp. k. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
26.91%
Total operating revenue
26.43%
Operating profit (EBIT)
24.97%
EBITDA
25.17%
Net Profit (Loss) for the Period
10.67%
Total assets
28.93%
Total equity
75.57%
Operating Profit Margin (ROS)
-0.21%
Net Profit Margin
-1.45%
Return on Equity (ROE)
-36.34%
Debt to Equity Ratio
-43.15%
Quick Ratio
0.36%
Cash Ratio
0.38%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?